220 related articles for article (PubMed ID: 25847767)
1. Synthesis and anticancer activity of N-substituted 2-arylquinazolinones bearing trans-stilbene scaffold.
Mahdavi M; Pedrood K; Safavi M; Saeedi M; Pordeli M; Ardestani SK; Emami S; Adib M; Foroumadi A; Shafiee A
Eur J Med Chem; 2015 May; 95():492-9. PubMed ID: 25847767
[TBL] [Abstract][Full Text] [Related]
2. Anticancer effects of synthetic hexahydrobenzo [g]chromen-4-one derivatives on human breast cancer cell lines.
Pordeli M; Nakhjiri M; Safavi M; Ardestani SK; Foroumadi A
Breast Cancer; 2017 Mar; 24(2):299-311. PubMed ID: 27250840
[TBL] [Abstract][Full Text] [Related]
3. Novel quinazolin-4(3H)-one linked to 1,2,3-triazoles: Synthesis and anticancer activity.
Safavi M; Ashtari A; Khalili F; Mirfazli SS; Saeedi M; Ardestani SK; Rashidi Ranjbar P; Barazandeh Tehrani M; Larijani B; Mahdavi M
Chem Biol Drug Des; 2018 Jul; 92(1):1373-1381. PubMed ID: 29637699
[TBL] [Abstract][Full Text] [Related]
4. 3-(Dipropylamino)-5-hydroxybenzofuro[2,3-f]quinazolin-1(2H)-one (DPA-HBFQ-1) plays an inhibitory role on breast cancer cell growth and progression.
Rizza P; Pellegrino M; Caruso A; Iacopetta D; Sinicropi MS; Rault S; Lancelot JC; El-Kashef H; Lesnard A; Rochais C; Dallemagne P; Saturnino C; Giordano F; Catalano S; Andò S
Eur J Med Chem; 2016 Jan; 107():275-87. PubMed ID: 26599533
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis and evaluation of new quinazolin-4-one derivatives as apoptotic enhancers and autophagy inhibitors with potent antitumor activity.
ElZahabi HSA; Nafie MS; Osman D; Elghazawy NH; Soliman DH; El-Helby AAH; Arafa RK
Eur J Med Chem; 2021 Oct; 222():113609. PubMed ID: 34119830
[TBL] [Abstract][Full Text] [Related]
6. Halogenated flavanones as potential apoptosis-inducing agents: synthesis and biological activity evaluation.
Safavi M; Esmati N; Ardestani SK; Emami S; Ajdari S; Davoodi J; Shafiee A; Foroumadi A
Eur J Med Chem; 2012 Dec; 58():573-80. PubMed ID: 23174316
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, in vitro cytotoxicity and apoptosis inducing study of 2-aryl-3-nitro-2H-chromene derivatives as potent anti-breast cancer agents.
Rahmani-Nezhad S; Safavi M; Pordeli M; Ardestani SK; Khosravani L; Pourshojaei Y; Mahdavi M; Emami S; Foroumadi A; Shafiee A
Eur J Med Chem; 2014 Oct; 86():562-9. PubMed ID: 25216378
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and Evaluation of 2-Naphthaleno trans-Stilbenes and Cyanostilbenes as Anticancer Agents.
Madadi NR; Penthala NR; Ketkar A; Eoff RL; Trujullo-Alonso V; Guzman ML; Crooks PA
Anticancer Agents Med Chem; 2018; 18(4):556-564. PubMed ID: 28403783
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and cytotoxicity testing of novel 2-(3-substituted-6-chloro-1,1-dioxo-1,4,2-benzodithiazin-7-yl)-3-phenyl-4(3H)-quinazolinones.
Pomarnacka E; Maruszak M; Langowska K; Reszka P; Bednarski PJ
Arch Pharm (Weinheim); 2008 Aug; 341(8):485-90. PubMed ID: 18618486
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and antitumor activity of some 2, 3-disubstituted quinazolin-4(3H)-ones and 4, 6- disubstituted- 1, 2, 3, 4-tetrahydroquinazolin-2H-ones.
Abdel Gawad NM; Georgey HH; Youssef RM; El-Sayed NA
Eur J Med Chem; 2010 Dec; 45(12):6058-67. PubMed ID: 21051122
[TBL] [Abstract][Full Text] [Related]
11. Potential anti-proliferative agents from 1,4-benzoxazinone-quinazolin-4(3H)-one templates.
Bollu R; Banu S; Kasaboina S; Bantu R; Nagarapu L; Polepalli S; Jain N
Bioorg Med Chem Lett; 2017 Dec; 27(24):5481-5484. PubMed ID: 29089233
[TBL] [Abstract][Full Text] [Related]
12. New (E)-1-alkyl-1H-benzo[d]imidazol-2-yl)methylene)indolin-2-ones: Synthesis, in vitro cytotoxicity evaluation and apoptosis inducing studies.
Sharma P; Thummuri D; Reddy TS; Senwar KR; Naidu VGM; Srinivasulu G; Bharghava SK; Shankaraiah N
Eur J Med Chem; 2016 Oct; 122():584-600. PubMed ID: 27448916
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and antitumor evaluation of trimethoxyanilides based on 4(3H)-quinazolinone scaffolds.
Mohamed MA; Ayyad RR; Shawer TZ; Abdel-Aziz AA; El-Azab AS
Eur J Med Chem; 2016 Apr; 112():106-113. PubMed ID: 26890117
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological evaluation of novel (E) stilbene-based antitumor agents.
Csuk R; Albert S; Siewert B; Schwarz S
Eur J Med Chem; 2012 Aug; 54():669-78. PubMed ID: 22749392
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological evaluation of a novel series of 6,8-dibromo-4(3H)quinazolinone derivatives as anticancer agents.
Ahmed MF; Youns M
Arch Pharm (Weinheim); 2013 Aug; 346(8):610-7. PubMed ID: 23873839
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis, and molecular docking studies of 2-(furan-2-yl)quinazolin-4-one derivatives as potential antiproliferative agents.
Ahmed MF; Belal A
Arch Pharm (Weinheim); 2015 Jul; 348(7):487-97. PubMed ID: 25921702
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and in vitro antitumor activity of novel N-substituted-4-phenyl/benzylphthalazin-1-ones.
Eldehna WM; Ibrahim HS; Abdel-Aziz HA; Farrag NN; Youssef MM
Eur J Med Chem; 2015 Jan; 89():549-60. PubMed ID: 25462265
[TBL] [Abstract][Full Text] [Related]
18. Parallel solution phase synthesis of 3,6,7-4(3H)-quinazolinones and evaluation of their antitumor activities against human cancer.
Wu H; Xie X; Liu G
J Comb Chem; 2010 May; 12(3):346-55. PubMed ID: 20196566
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, antitumor evaluation, and apoptosis-inducing activity of hydroxylated (E)-stilbenes.
Lion CJ; Matthews CS; Stevens MF; Westwell AD
J Med Chem; 2005 Feb; 48(4):1292-5. PubMed ID: 15715501
[TBL] [Abstract][Full Text] [Related]
20. Lemon Juice Mediated Synthesis of 3-Substituted Quinazolin-4(3H)-Ones and their Pharmacological Evaluation.
Prasad MG; Lakshmi CV; Katari NK; Jonnalagadda SB; Pal M
Anticancer Agents Med Chem; 2019; 19(16):2001-2009. PubMed ID: 31340741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
